iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
iCAD,a global medical technology leader providing innovative cancer detection and therapy solutions, announced the Board of Directors has approved the appointment of Daniel Shea, CPA, as interim Chief Financial Officer (CFO), effective immediately. The Company has launched a search for a full-time CFO, with the goal of completing that process in approximately 90 days. Also, after a rigorous search process, iCAD hired Bill Keyes as Senior Vice President, US Commercial Sales, AI.
“We are pleased to welcome Mr. Shea and Mr. Keyes to the iCAD senior leadership team, as they each offer remarkable experiences and talents that are uniquely positioned to benefit the Company during what is currently an exciting time of transformation as we shift to a more sustainable partnership-based and recurring revenue model for our AI business. Both Mr. Shea and Mr. Keyes offer impressive business acumen and proven track records of driving transformation and growth, and we are confident that they will be tremendous assets to the iCAD team,” said Stacey Stevens, President and CEO of iCAD, Inc. “On behalf of the Company and the entire Board of Directors, I would like to thank Steve Sarno for his work as our previous interim CFO, and I look forward to working with Mr. Shea and Mr. Keyes as we continue in our journey to execute our strategic vision, grow our business and enhance our team with experienced leaders who know how to deliver high-impact results.”
Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI
With more than 30 years of experience building, leading and advising finance functions in both private and public companies, Mr. Shea previously served as CFO at companies including Pressure Biosciences, Inc., 4D Technologies, and Easterly Partners Group. He earned a BS in Accounting and Finance from Boston College and is a Certified Public Accountant.
“I am honored to accept this role as interim CFO and look forward to working with iCAD’s talented and passionate team, who are dedicated to revolutionizing the way cancer is detected and treated,” said Mr. Shea.
As a seasoned commercial leader with more than 35 years of healthcare technology experience at companies ranging from entrepreneurial start-up environments to Fortune 500 companies, Mr. Keyes offers a consistent track record of success in building and leading sales teams, driving growth via enterprise sales and software as a service (SaaS) expertise. He previously held a range of senior leadership positions, most recently serving as Chief Growth Officer at i2i Population Health and Senior Vice President, Sales and Marketing, at Connecture. Mr. Keyes earned a Master of Business Administration from DePaul University and a Bachelor of Business Administration from the University of Iowa.
AI News: An Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai
“iCAD offers a winning combination of leading-edge technologies and smart, talented staff,” said Mr. Keyes. “I am honored to accept this position and am excited to work with the team as we embark upon a new and exciting era of opportunity and progress as we enter 2023.
AiThority Interview : AiThority Interview with Hardy Myers, SVP of Business Development & Strategy at Cognigy
[To share your insights with us, please write to firstname.lastname@example.org]
Comments are closed.